Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Campania Luigi Vanvitelli
To evaluate if the supplementation for three months with Lactobacillus reuteri DSM 17938 (108 CFU) + Vitamin D3 (400 IU) result in a reduction of the degree of allergic bronchial inflammation, measured with the Fractional exhaled nitric oxide (FeNO) and with a series of markers of bronchial inflammation (measured at 'beginning and at the end of the treatment on exhaled condensate): Interleukin 2(IL-2); Interleukin 4 (IL-4); Interleukin 10(IL-10); Interferon γ (IFN-γ).
Age
6–14
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged between 6 and 14 years old, of both sexes
Diagnosis of mild / moderate persistent asthma (GINA step 2/3)
